Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat

European Neuropsychopharmacology

Volumn 17, Issue 6-7, 2007, Pages 417-429

  Abumaria, Nashat ^a   Rygula, Rafal ^a,b,c   Hiemke, Christoph ^d   Fuchs, Eberhard ^a,b,c   Havemann Reinecke, Ursula ^b,c   Rüther, Eckart ^b,c   Flügge, Gabriele ^a,b  

^a GERMAN PRIMATE CENTER   (Germany)

^b DFG Research Center Molecular Physiology of the Brain (CMPB)   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antidepressant; Gene expression; KEYWORDS; Serotonin; Social stress; Synaptic plasticity; Tryptophan hydroxylase

Indexed keywords

AUTORECEPTOR; CITALOPRAM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GENE PRODUCT; GLIAL N MYC DOWNSTREAM REGULATED GENE 2; GLYCOPROTEIN; MESSENGER RNA; NEURON SPECIFIC ENOLASE; NEUROTRANSMITTER; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SYNAPTIC VESICLE GLYCOPROTEIN 2B; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; MALE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM; SOCIAL STRESS; SYMPTOMATOLOGY; UPREGULATION;

ANIMALS; CITALOPRAM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; RAPHE NUCLEI; RATS; RATS, WISTAR; RNA; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR; STRESS; TRYPTOPHAN HYDROXYLASE;

EID: 33947679272     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.08.009     Document Type: Article

References (92)

1. Abumaria N., Rygula R., Havemann-Reinecke U., Rüther E., Bodemer W., Roos C., and Flügge G. Identification of genes regulated by chronic social stress in the dorsal raphe nucleus. Cell. Mol. Neurobiol. 26 (2006) 145-162
2. Alfonso J., Pollevick G.D., Van Der Hart M.G., Flügge G., Fuchs E., and Frasch A.C. Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur. J. Neurosci. 19 (2004) 659-666
3. Alfonso J., Fernandez M.E., Cooper B., Flügge G., and Frasch A.C. The stress-regulated protein M6a is a key modulator for neurite outgrowth and filopodium/spine formation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17196-17201
4. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8 (2005) 365-371
5. Andriamampandry C., Muller C., Schmidt-Mutter C., Gobaille S., Spedding M., Aunis D., and Maitre M. Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol. Pharmacol. 62 (2002) 1332-1338
6. Azmitia Jr. E.C., and McEwen B.S. Adrenalcortical influence on rat brain tryptophan hydroxylase activity. Brain Res. 78 (1974) 291-302
7. Bach-Mizrachi H., Underwood M.D., Kassir S.A., Bakalian M.J., Sibille E., Tamir H., Mann J.J., and Arango V. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31 (2006) 814-824
8. Baumann P., Hiemke C., Ulrich S., Gaertner I., Rao M.L., Eckermann G., Gerlach M., Kuss H.J., Laux G., Muller-Oerlinghausen B., Riederer P., and Zernig G. Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline. Ther. Drug Monit. 26 (2004) 167-170
9. Bock J.B., and Scheller R.H. SNARE proteins mediate lipid bilayer fusion. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12227-12229
10. Chamas F., Serova L., and Sabban E.L. Tryptophan hydroxylase mRNA levels are elevated by repeated immobilization stress in rat raphe nuclei but not in pineal gland. Neurosci. Lett. 267 (1999) 157-160
11. Chamas F.M., Underwood M.D., Arango V., Serova L., Kassir S.A., Mann J.J., and Sabban E.L. Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei. Biol. Psychiatry 55 (2004) 278-283
12. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Brain Res. Rev. 18 (1993) 1-32
13. Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 14 (2000) 139-151
14. Chen Y.A., Scales S.J., Patel S.M., Doung Y.C., and Scheller R.H. SNARE complex formation is triggered by Ca2+ and drives membrane fusion. Cell 97 (1999) 165-174
15. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12796-12801
16. Czeh B., Simon M., Schmelting B., Hiemke C., and Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31 (2006) 1616-1626
17. Darmon M.C., Guibert B., Leviel V., Ehret M., Maitre M., and Mallet J. Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J. Neurochem. 51 (1988) 312-316
18. de Montigny C., Chaput Y., and Blier P. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J. Clin. Psychiatry 51 Suppl. B (1990) 4-8
19. Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352 (1998) 1754-1755
20. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
21. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46 (1999) 1181-1191
22. D'Souza D.N., Zhang Y., Garcia F., Battaglia G., and Van de Kar L.D. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R390-R397
23. El Mansari M., Sanchez C., Chouvet G., Renaud B., and Haddjeri N. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30 (2005) 1269-1277
24. Fiebig K.M., Rice L.M., Pollock E., and Brunger A.T. Folding intermediates of SNARE complex assembly. Nat. Struct. Biol. 6 (1999) 117-123
25. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
26. Gundlah C., Alves S.E., Clark J.A., Pai L.Y., Schaeffer J.M., and Rohrer S.P. Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe. Biol. Psychiatry 57 (2005) 938-942
27. Hanoun N., Mocaer E., Boyer P.A., Hamon M., and Lanfumey L. Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology 47 (2004) 515-526
28. Hartter S., Weigmann H., and Hiemke C. Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection. J. Chromatogr., B, Biomed. Sci. Appl. 740 (2000) 135-140
29. Hattori T., Takei N., Mizuno Y., Kato K., and Kohsaka S. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci. Res. 21 (1995) 191-198
30. Haycock J.W., Kumer S.C., Lewis D.A., Vrana K.E., and Stockmeier C.A. A monoclonal antibody to tryptophan hydroxylase: applications and identification of the epitope. J. Neurosci. Methods 114 (2002) 205-212
31. Janz R., Goda Y., Geppert M., Missler M., and Sudhof T.C. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24 (1999) 1003-1016
32. Kawahara H., Yoshida M., Yokoo H., Nishi M., and Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett. 162 (1993) 81-84
33. Kendler K.S., Karkowski L.M., and Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 156 (1999) 837-841
34. Keuker J.I., Keijser J.N., Nyakas C., Luiten P.G., and Fuchs E. Aging is accompanied by a subfield-specific reduction of serotonergic fibers in the tree shrew hippocampal formation. J. Chem. Neuroanat. 30 (2005) 221-229
35. Kessler R.C. The effects of stressful life events on depression. Annu. Rev. Psychol. 48 (1997) 191-214
36. Kirby L.G., Chou-Green J.M., Davis K., and Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 760 (1997) 218-230
37. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274 (1995) 866-876
38. Lambert K.G., Gerecke K.M., Quadros P.S., Doudera E., Jasnow A.M., and Kinsley C.H. Activity-stress increases density of GFAP-immunoreactive astrocytes in the rat hippocampus. Stress 3 (2000) 275-284
39. Landgrebe J., Welzl G., Metz T., van Gaalen M.M., Ropers H., Wurst W., and Holsboer F. Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J. Psychiatr. Res. 36 (2002) 119-129
40. Landry M., Frasier M., Chen Z., Van De Kar L.D., Zhang Y., Garcia F., and Battaglia G. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin. Synapse 58 (2005) 102-109
41. Lazzell D.R., Belizaire R., Thakur P., Sherry D.M., and Janz R. SV2B regulates synaptotagmin 1 by direct interaction. J. Biol. Chem. 279 (2004) 52124-52131
42. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., and Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 141-148
43. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., Hamon M., and Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
44. Lonze B.E., Riccio A., Cohen S., and Ginty D.D. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34 (2002) 371-385
45. Lonze B.E., and Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35 (2002) 605-623
46. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8 (1997) 523-532
47. Magarinos A.M., and McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 69 (1995) 83-88
48. Magarinos A.M., McEwen B.S., Flügge G., and Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J. Neurosci. 16 (1996) 3534-3540
49. Magarinos A.M., Verdugo J.M., and McEwen B.S. Chronic stress alters synaptic terminal structure in hippocampus. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14002-14008
50. Malek Z.S., Dardente H., Pevet P., and Raison S. Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles. Eur. J. Neurosci. 22 (2005) 895-901
51. Mangiavacchi S., Masi F., Scheggi S., Leggio B., De Montis M.G., and Gamberana C. Long-term behavioral and neurochemical effects of chronic stress exposure in rats. J. Neurochem. 79 (2001) 1113-1121
52. Manji H.K., and Duman R.S. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol. Bull. 35 (2001) 5-49
53. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
54. Marangos P.J., Schmechel D.E., Parma A.M., and Goodwin F.K. Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase. Brain Res. 190 (1980) 185-193
55. Marangos P.J., and Schmechel D.E. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 10 (1987) 269-295
56. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev., Mol. Cell Biol. 2 (2001) 599-609
57. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 23 (2002) 921-939
58. McEwen B.S., Magarinos A.M., and Reagan L.P. Structural plasticity and tianeptine: cellular and molecular targets. Eur. Psychiatr. 17 Suppl 3 (2002) 318-330
59. Meaney M.J., and Szyf M. Maternal care as a model for experience-dependent chromatin plasticity. Trends Neurosci. 28 (2005) 456-463
60. Montgomery S.A., and Djarv L. The antidepressant efficacy of citalopram. Int. Clin. Psychopharmacol. 11 Suppl 1 (1996) 29-33
61. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J.M., Landgraf R., and Holsboer F. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7 (1995) 841-845
62. Nakamura K., Sugawara Y., Sawabe K., Ohashi A., Tsurui H., Xiu Y., Ohtsuji M., Lin Q.S., Nishimura H., Hasegawa H., and Hirose S. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J. Neurosci. 26 (2006) 530-534
63. Nestler E.J. Antidepressant treatments in the 21st century. Biol. Psychiatry 44 (1998) 526-533
64. Neumaier J.F., Root D.C., and Hamblin M.W. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 15 (1996) 515-522
65. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
66. Nichols N.R. Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes. Ann. N.Y. Acad. Sci. 1007 (2003) 349-356
67. Nichols N.R., and Finch C.E. Gene products of corticosteroid action in hippocampus. Ann. N.Y. Acad. Sci. 746 (1994) 145-154
68. Osen-Sand A., Catsicas M., Staple J.K., Jones K.A., Ayala G., Knowles J., Grenningloh G., and Catsicas S. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364 (1993) 445-448
69. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147 (1999) 162-167
70. Palkovits M., Brownstein M., Kizer J.S., Saavedra J.M., and Kopin I.J. Effect of stress on serotonin concentration and tryptophan hydroxylase activity of brain nuclei. Neuroendocrinology 22 (1976) 298-304
71. Parker N.G., and Brown C.S. Citalopram in the treatment of depression. Ann. Pharmacother. 34 (2000) 761-771
72. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2 Ed. (1986), Academic Press, Inc., San Diego
73. Paykel E.S. Stress and affective disorders in humans. Semin. Clin. Neuropsychiatry 6 (2001) 4-11
74. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 31 (2003) e73
75. Raab A. Serotonin metabolism in discrete brain areas and sociopsychic stress in tupaia (Tupaia-Belangeri). Z. Vergl. Physiol. 72 (1971) 54-66
76. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 245 (1997) 154-160
77. Rygula R., Abumaria N., Flügge G., Fuchs E., Rüther E., and Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav. Brain Res. 162 (2005) 127-134
78. Rygula R., Abumaria N., Flügge G., Hiemke C., Fuchs E., Rüther E., and Havemann-Reinecke U. Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav. Pharmacol. 17 (2006) 19-29
79. Sakowski S.A., Geddes T.J., Thomas D.M., Levi E., Hatfield J.S., and Kuhn D.M. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res. 1085 (2006) 11-18
80. Sanchez C., Bergqvist P.B., Brennum L.T., Gupta S., Hogg S., Larsen A., and Wiborg O. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl.) 167 (2003) 353-362
81. Sollner T., Whiteheart S.W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., and Rothman J.E. SNAP receptors implicated in vesicle targeting and fusion. Nature 362 (1993) 318-324
82. Spurlock G., Buckland P., O'Donovan M., and McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33 (1994) 433-440
83. Stoscheck C.M. Quantitation of protein. Methods Enzymol. 182 (1990) 50-68
84. Takahashi K., Yamada M., Ohata H., Momose K., Higuchi T., Honda K., and Yamada M. Expression of Ndrg2 in the rat frontal cortex after antidepressant and electroconvulsive treatment. Int. J. Neuropsychopharmacol. 8 (2005) 381-389
85. Takei N., Kondo J., Nagaike K., Ohsawa K., Kato K., and Kohsaka S. Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J. Neurochem. 57 (1991) 1178-1184
86. Thierry A.M., Javoy F., Glowinski J., and Kety S.S. Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat: I. Modifications of norepinephrine turnover. J. Pharmacol. Exp. Ther. 163 (1968) 163-171
87. Underwood M.D., Khaibulina A.A., Ellis S.P., Moran A., Rice P.M., Mann J.J., and Arango V. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol. Psychiatry 46 (1999) 473-483
88. Van Der Hart M.G., Czeh B., de Biurrun G., Michaelis T., Watanabe T., Natt O., Frahm J., and Fuchs E. Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol. Psychiatry 7 (2002) 933-941
89. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., and Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
90. Wong M.L., O'Kirwan F., Hannestad J.P., Irizarry K.J., Elashoff D., and Licinio J. St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol. Psychiatry 9 (2004) 237-251
91. Xu T., and Bajjalieh S.M. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat. Cell Biol. 3 (2001) 691-698
92. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217